TissueGUARD

We are pleased to announce that TissueGUARD's leadership team will present our latest developments in ophthalmic medical devices and regenerative biotechnologies at the World Eye Bank Symposium (WEBS 2026) in Prague on 25 June 2026.
Simone Arndt, M.Sc. will present our novel DSAEK devices and graft preparation technology, while Mikhail Tsurkan, PhD, will present our work on regenerative medicine approaches using bioengineered Descemet membranes for corneal endothelial replacement.
These scientific presentations highlight our ongoing efforts to advance corneal transplantation through innovative research and technology development. We look forward to engaging with colleagues from the global eye banking, corneal surgery, and ophthalmology communities at WEBS 2026.

TissueGUARD is committed to advancing corneal transplantation through innovative device solutions. Visit us at EBAA 2026 to explore our latest developments in DMEK and DSAEK tissue preparation and delivery. We look forward to presenting our innovations to eye banks and corneal surgeons.

TissueGUARD will be exhibiting at EEBA 2026 in A Coruña, Spain (19–21 March).
We will present our DMEK keratoplasty device, currently in CE certification, and introduce our latest DSAEK injector development, enabling graft injection using a technique similar to DMEK. Its manufacturing was supported by the European Union and Sächsische Aufbaubank - Förderbank - co-funding.
If you are attending EEBA, feel free to stop by our booth.

International Women’s Day! We wish all women worldwide a successful and fulfilling journey. At TissueGUARD, we especially celebrate the incredible women driving innovation in medicine, medical technology, and patient care.

We’re excited to exhibit once again at the Advanced Therapies USA conference, this time in Philadelphia!
Beyond our work in innovative medical devices for ophthalmology, TissueGUARD is developing advanced substitution therapies for diseases affecting the cornea, retina, and ischemia. Visit us at Stand 9 in the Startup Zone on November 12-13 to discover our technologies for tissue formation, organoid development, and next-generation cell therapies in regenerative medicine for ophthalmology (cornea, retina) and ischemia (stroke).
Looking forward to connecting with you there!